Home LiteratureArticle Details
PMID: 374424 Published · ppublish English Journal Article

Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.

The Journal of clinical investigation ·Vol. 63 ·No. 4 ·1979-04-00 ·Pages 772-84

Leijh PC, van den Barselaar MT, van Zwet TL, Daha MR, van Furth R

Abstract

The role of serum factors in the intracellular killing of bacteria by monocytes was studied on the basis of an assay independent of phagocytosis. After 3 min of phagocytosis of preopsonized bacteria and removal of noningested bacteria, the monocytes containing bacteria are reincubated for various periods and the number of unkilled bacteria is determined by a microbiological method after lysis of the cells. Evidence that this assay measures the killing of ingested bacteria was provided by scanning electron microscopy, lysostaphin treatment, and the effect on the rate of intracellular killing of inactivated serum lacking specific opsonic activity. Intracellular killing of Staphylococcus aureaus, S. epidermidis, and Escherichia coli by human monocytes does not occur or is low in the absence of serum, and maximal killing is only reached when fresh serum is present; intermediate values are obtained in the presence of heat-inactivated serum. These findings indicate that complement stimulates intracellular killing. Isolated heterogeneous immunoglobulin (Ig)G, pFc fragments of heterogeneous IgG, and both IgG1 and IgG3 stimulate intracellular killing of S. aureaus by monocytes to the same degree as heat-inactivated serum. Sphingomyelinase, which decreases the number of Fc receptors, and neuraminidase, which increases these receptors, respectively, decreased and increased the intracellular killing, whereas anti-monocyte serum completely abolished the stimulation of intracellular killing by inactivated serum. These results prove that interaction of the Fc receptor with the Fc part of IgG is required for the intracellular killing. Inhibition of the activation of complement components via the alternative pathway gave a considerable reduction in the intracellular killing of S. aureaus; impairment of the activation via the classical pathway had no effect. The addition of complement components to heat-inactivated serum showed that intracellular killing is maximal only when C3b is generated. Reduction of the number of C3b receptors in the membrane by trypsin or pronase decreased intracellular killing in the presence of fresh serum; anti-monocyte serum completely abolished the stimulation of intracellular killing by fresh serum. These results lead to the conclusion that intracellular killing is also dependent on the interaction between C3b and its receptor in the membrane.

MeSH Terms
Blood Bactericidal Activity Complement C3/physiology Complement System Proteins/physiology Escherichia coli Humans Immunoglobulin Fab Fragments/physiology Immunoglobulin Fc Fragments/physiology Immunoglobulin G/physiology Immunoglobulin M/physiology Kinetics Monocytes/immunology,physiology Opsonin Proteins/physiology Phagocytosis Staphylococcus
Chemicals
Complement C3 Immunoglobulin Fab Fragments Immunoglobulin Fc Fragments Immunoglobulin G Immunoglobulin M Opsonin Proteins Complement System Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Leijh P C
van den Barselaar M T
van Zwet T L
Daha M R
van Furth R
References (38)
38 references, click to expand
  1. Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.
    Arch Biochem Biophys. 1960 Aug;89:230-44 PMID: 14427334
  2. DISSOCIATION OF PHAGOCYTOSIS AND INTRACELLULAR KILLING OF STAPHYLOCOCCUS AUREUS BY HUMAN BLOOD LEUKOCYTES.
    J Immunol. 1963 May;90:804-9 PMID: 14053299
  3. Diffusion-in-gel methods for immunological analysis. II.
    Prog Allergy. 1962;6:30-154 PMID: 14482809
  4. Interactions between rabbit polymorphonuclear leucocytes and staphylococci.
    J Exp Med. 1959 Sep 1;110:419-43 PMID: 13811057
  5. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  6. Action of sphingomyelinase C and other lipid-specific agents as inhibitors of Fc binding and locomotion in human leucocytes.
    Immunology. 1977 Sep;33(3):407-12 PMID: 198359
  7. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    J Immunol. 1976 Oct;117(4):1282-7 PMID: 185296
  8. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes.
    Infect Immun. 1977 Aug;17(2):313-8 PMID: 330404
  9. The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state.
    J Exp Med. 1978 Jul 1;148(1):1-17 PMID: 670884
  10. Specific antisera against human blood cells applicable in the indirect immunofluorescence technique.
    Scand J Immunol. 1976;5(9):1065-74 PMID: 795002
  11. 2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect.
    J Exp Med. 1976 Dec 1;144(6):1465-83 PMID: 1032901
  12. 2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages II. Dissociation of the inhibitory effects of 2-deoxyglucose on phagocytosis and ATP generation.
    J Exp Med. 1976 Dec 1;144(6):1484-93 PMID: 1003099
  13. Effects of activated complement components on enzyme secretion by macrophages.
    Immunology. 1976 Nov;31(5):781-8 PMID: 992710
  14. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    J Exp Med. 1975 Oct 1;142(4):856-63 PMID: 1185108
  15. Activation of the alternate pathway of human complements by rabbit cells.
    J Immunol. 1974 Jul;113(1):348-58 PMID: 4134064
  16. Recognition of human IgM subgroups by quantitative measurement.
    Clin Exp Immunol. 1973 Sep;15(1):103-11 PMID: 4128890
  17. Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.
    Science. 1968 Dec 13;162(3859):1281-3 PMID: 4177339
  18. Batch preparation of rabbit gammaG globulin with deae-cellulose.
    Immunochemistry. 1969 Sep;6(5):723-31 PMID: 4186540
  19. Influence of serum on the bactericidal activity of neutrophil granulocytes.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Oct;81(5):621-6 PMID: 4525528
  20. Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G.
    J Exp Med. 1976 Jun 1;143(6):1551-6 PMID: 178824
  21. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.
    J Clin Invest. 1975 Nov;56(5):1155-63 PMID: 171281
  22. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes.
    J Lab Clin Med. 1975 Feb;85(2):245-52 PMID: 163283
  23. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).
    J Immunol. 1973 Jan;110(1):128-38 PMID: 4734384
  24. Immunochemical quantitation of antigens by single radial immunodiffusion.
    Immunochemistry. 1965 Sep;2(3):235-54 PMID: 4956917
  25. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants.
    Nature. 1976 Aug 26;262(5571):795-7 PMID: 785284
  26. Superoxide production by phagocytic leukocytes.
    J Exp Med. 1975 Jan 1;141(1):257-62 PMID: 804030
  27. Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes.
    J Exp Med. 1976 Sep 1;144(3):788-809 PMID: 1085341
  28. Influence of IgG, F(ab')2 and IgM on the phagocytic and bactericidal activities of human neutrophil granulocytes.
    Acta Pathol Microbiol Scand C. 1976 Apr;84(2):119-23 PMID: 1266630
  29. Influence of antibodies and thermolabile serum factors on the bactericidal activity of human neutrophil granulocytes.
    Acta Pathol Microbiol Scand C. 1976 Apr;84(2):112-8 PMID: 1266629
  30. Phagocytosis in rat Kupffer cells in vitro.
    Exp Cell Res. 1976 May;99(2):319-27 PMID: 944634
  31. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.
    J Exp Med. 1975 Nov 1;142(5):1263-82 PMID: 1194852
  32. Influence of therapeutic concentrations of phenylbutazone on granulocyte function.
    Acta Pathol Microbiol Scand B. 1975 Apr;83(2):100-2 PMID: 1155108
  33. H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.
    J Clin Invest. 1975 May;55(5):945-55 PMID: 1123431
  34. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.
    J Immunol. 1971 Dec;107(6):1535-46 PMID: 5120396
  35. A modified assay of neutrophil function: use of lysostaphin to differentiate defective phagocytosis from impaired intracellular killing.
    J Lab Clin Med. 1971 Aug;78(2):316-22 PMID: 5567568
  36. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    J Immunol. 1969 Mar;102(3):533-43 PMID: 5813010
  37. Phagocytosis: the engulfment stage.
    Semin Hematol. 1968 Apr;5(2):134-55 PMID: 5690199
  38. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
    Immunochemistry. 1966 Mar;3(2):111-35 PMID: 5960883
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1979-04-00
Pages
772-84
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC372014
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com